The Termination of the Contract concerning OTC MedicineDaiichi Sankyo Company, LTD • September 21st, 2006 • Pharmaceutical preparations
Novartis Pharma K. K. (head office in Minato-ku, Tokyo: Nobuyuki Baba, President) and Sankyo Co., Ltd. (head office in Chuo-ku, Tokyo: Yasuhiro Ikegami, President) which is the affiliate of Daiichi Sankyo Co., Ltd. (head office in Chuo-ku, Tokyo: Takashi Shoda, President) have agreed to terminate the agreement concluded in January 2004 concerning Lamisil and Nicotinell TTS at the end of December, 2006.
